Browse our new articles from the PICC Medical Team related to Parkinson’s research and the Parkinson’s Institute and Clinical Center.
Disease-Modifying Therapy for Parkinson’s Disease
The holy grail of Parkinson’s disease research is to develop an agent that will slow or halt progression of PD. Today, the treatment of Parkinson’s disease consists of alleviating symptoms: the tremor, slowness, and stiffness of PD. Carbidopa/levodopa is the most...
At The Forefront of Essential Tremor Research
Researchers from the Parkinson’s Institute and Clinical Center (PICC) participated in the largest therapeutic trial ever conducted in essential tremor (ET) called PROspective study for SymPtomatic relief of Essential tremor with Cala Therapy (PROSPECT)....
Do Statins Help Parkinson’s Disease?
Statins, including the drug simvastatin, are cholesterol-lowering medications typically prescribed by primary care physicians and cardiologists. They lower the body’s production of new cholesterol and can also reduce artery-clogging plaques in...